Market Tracker

01/16 1:05pm ET

Amarin Corporation PLC (NASDAQ:AMRN)

3.02
Delayed Data
As of Jan 13
 +0.03 / +1.00%
Today’s Change
1.24
Today|||52-Week Range
3.65
-1.95%
Year-to-Date
More Innovation, Less Regulation: 2 Biotech Stocks That Could Soar in 2017
Jan 11 / MotleyFool.com - Paid Partner Content
1 Reason Amarin's Stock Skyrocketed in 2016
Jan 10 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close2.99
Today’s open3.00
Day’s range2.97 - 3.03
Volume1,948,430
Average volume (3 months)2,605,955
Market cap$815.3M
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-159.93%
Earnings growth (this year)+35.38%
Earnings growth (next 5 years)-249.00%
Revenue growth (last year)+51.17%
P/E ratioNM
Price/Sales4.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AMRIAlbany Molecular Res...-0.14-0.77%
RGNXRegenxbio Inc+0.75+3.99%
BSTCBiospecifics Technol...-0.45-0.83%
CDXSCodexis Inc+0.05+1.03%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$81.6M
Annual profit (last year)-$148.8M
Net profit margin-182.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John F. Thero
SVP-
Manufacturing Operations
Derek Kalinowski
Corporate headquarters
Dublin, Dublin

Forecasts